<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6538">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01897103</url>
  </required_header>
  <id_info>
    <org_study_id>S12-03123</org_study_id>
    <nct_id>NCT01897103</nct_id>
  </id_info>
  <brief_title>Platelet Activity in Vascular Surgery for Thrombosis and Bleeding</brief_title>
  <acronym>PIVOTAL</acronym>
  <official_title>Platelet Activity in Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers
      during the perioperative period. The goal is to develop a clinically useful assessment of
      platelet/coagulation activity for risk stratification that may ultimately serve as a target
      for therapeutic intervention. This study will enroll 200 patients with peripheral artery
      disease undergoing vascular surgery. PIVOTAL is funded by American Heart Association and is
      scheduled to begin enrollment in July 2013 for approximately two years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To describe platelet activity among PAD subjects undergoing vascular surgery.

      To determine whether preoperative platelet activity measurements are independently
      associated with perioperative cardiovascular events.

      To identify demographic, clinical, and surgical factors associated with postoperative
      platelet activity measurements in patients with established PAD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Platelet Activity</measure>
    <time_frame>two years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The main outcome measures are platelet activity, coagulation markers, platelet mapping and profiling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative Events</measure>
    <time_frame>Two-years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Thrombotic and Bleeding events</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Peripheral Vascular Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Carotid Stenosis</condition>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Aortic Aneurysm, Thoracic</condition>
  <condition>Amputation, Wound</condition>
  <condition>Thrombectomy/Embolectomy</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, plasma, platelet RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study Population will be selected from the inpatient setting at NYU Medical Center and
        Bellevue Hospital as well as the outpatient setting in the Faculty Group Practice.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects undergoing non emergent vascular surgery

          -  Use of aspirin within 48 hours prior to surgery

          -  Age &gt; 21 years of age

          -  Able and willing to provide written informed consent for the study

        Exclusion Criteria:

          -  Use of any anticoagulant (Coumadin, heparin) within 24 hours to surgery

          -  Use of any Nonsteroidal Antiinflammatory Drug (NSAID) (such as ibuprofen, naproxen,
             etc.) within 72 hours

          -  Thrombocytopenia (platelet count&lt;100) or Thrombocytosis (platelet count&gt;500),

          -  Anemia (hemoglobin&lt;9),

          -  Severe kidney disease (CrCl&lt;30ml/min),

          -  Any known hemorrhagic diathesis.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey S Berger, MD, MS, FAHA, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adriana Perez, MD</last_name>
    <phone>305-310-9408</phone>
    <email>adriana.perez@nyumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tammy Seney</last_name>
    <phone>212-263-3627</phone>
    <email>tammy.seney@nyumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York University School Of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Perez, MD</last_name>
      <phone>212-263-9493</phone>
      <email>adriana.perez@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Edna Bissoon, BA</last_name>
      <phone>646-501-2730</phone>
      <email>edna.bissoon@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Caron Rockman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Derya Unutmaz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana Perez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline Bott, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maya Rubin, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bellevue Hospital Center, South Manhattan Healthcare Network</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Perez, MD</last_name>
      <phone>212-263-9493</phone>
      <email>adriana.perez@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Edna Bissoon, BA</last_name>
      <phone>646-501-2730</phone>
      <email>edna.bissoon@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Berger, MD, MS, FAHA, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caron Rockman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana Perez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rubin Maya, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Derya Unutmaz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline Bott, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berger JS, Hiatt WR. Medical therapy in peripheral artery disease. Circulation. 2012 Jul 24;126(4):491-500. doi: 10.1161/CIRCULATIONAHA.111.033886. Review.</citation>
    <PMID>22825411</PMID>
  </reference>
  <reference>
    <citation>Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost. 2013 Jan;109(1):85-92. doi: 10.1160/TH12-03-0202. Epub 2012 Dec 6.</citation>
    <PMID>23223800</PMID>
  </reference>
  <reference>
    <citation>Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010 Jan;8(1):148-56. doi: 10.1111/j.1538-7836.2009.03584.x. Epub 2009 Aug 19. Review.</citation>
    <PMID>19691485</PMID>
  </reference>
  <reference>
    <citation>Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2012 Jun 27. [Epub ahead of print]</citation>
    <PMID>22739687</PMID>
  </reference>
  <reference>
    <citation>Sharma G, Berger JS. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data. J Thromb Thrombolysis. 2011 Aug;32(2):201-8. doi: 10.1007/s11239-011-0590-9. Review.</citation>
    <PMID>21562837</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 23, 2014</lastchanged_date>
  <firstreceived_date>July 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York University School of Medicine</investigator_affiliation>
    <investigator_full_name>Jeffrey Berger</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine (Cardiology and Hematology) and Surgery (Vascular Surgery);  Director of Cardiovascular Thrombosis</investigator_title>
  </responsible_party>
  <keyword>Peripheral Artery Disease</keyword>
  <keyword>Endarterectomy (Carotid)</keyword>
  <keyword>Aortic Aneurysm, Abdominal</keyword>
  <keyword>Aortic Aneurysm, Thoracic</keyword>
  <keyword>Amputation</keyword>
  <keyword>Platelet Activity</keyword>
  <keyword>Thrombin</keyword>
  <keyword>Transcriptomics</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
